key: cord-0814582-en7hel0v
authors: Tessas, I.; Kluger, N.
title: Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID‐19 vaccine
date: 2021-06-11
journal: J Eur Acad Dermatol Venereol
DOI: 10.1111/jdv.17422
sha: d059c742cd0926c57aaf21e67e3dc53873848f87
doc_id: 814582
cord_uid: en7hel0v

As vaccination campaign against SARS-CoV-2 is on-going worldwide, dermatologists are witnessing an increasing number of cutaneous adverse events. Delayed hypersensitivity reactions at the site of injections with mRNA-1273 (Moderna) [1] and BNT162b2 (Pfizer-BioNtech) vaccines [2] are now known as "COVID-arms".

and inner side of the left arm (Fig. 1b) that followed approximately C5-C6 dermatomes. A diagnosis of HZ was made. He still presented the local reaction at the site of injection (Fig. 1c) . He received oral valaciclovir thrice a day for 2 weeks. Evolution was favourable, although postzoster neuropathic pain lasted for a month. He had mild varicella during childhood and acknowledged that the very same period was stressful, but denied any other immunosuppressive factor. He received his second injection of BNT162b2 vaccine on 21st April without side effect.

In the multinational placebo-controlled study that included 43 548 participants for BNT162b2 vaccination, 6 27%, 21% and 1% of the patients in the vaccination group reported an adverse event, a related event and severe event, respectively. However, HZ was not mentioned. At the time of writing this manuscript, we had found no report of HZ after mRNA-1273 vaccine.

Arguments that support in our case a link between SARS-CoV-2 vaccination and HZ include the following: (i) short delay of onset after vaccination; (ii) eruption on the same side as the vaccinated arm; (iii) a previous case of HZ after SARS-CoV-2 vaccination 5 ; (iv) numerous cases of HZ have been described in critically-ill or seemingly immunocompetent COVID-19 patients [7] [8] [9] ; and (v) cases of herpes viruses reactivations reported after various vaccinations. 10 HZ in COVID-19 patients may be related to physical and emotional stress associated with acute illness and also to COVID-19-induced lymphopenia and functional impairment of T cells. 8, 9 It is likely that immune dysregulation created by the vaccine played a role in the reactivation of latent Varicella Zoster Virus infection in our case as in the previous on, 5 although we cannot rule out a fortuitous event.

Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2

Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers

Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination

Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine

Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence?

C4591001 Clinical trial group. safety and efficacy of the BNT162b2 mRNA covid-19 vaccine

Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19

Herpes zoster in COVID-19-positive patients

Herpes zoster ophthalmicus in COVID-19 patients

Reaktivierung von Herpesviren-Infektionen durch Impfungen: Evidenz oder Koinzidenz?

The patient in this manuscript has given written informed consent to publication of their case details

None.